Abstract:
Introduction In many societies, the prevalence of chronic pain following breast cancer therapy ranges from 25% to 60%. Patients
undergoing surgery may be more likely to experience chronic, often neuropathic pain after surgery due to the mechanism of post-
mastectomy pain syndrome (PMPS), pain sensitivity, and/or central sensitization. PMPS is evaluated and reevaluated using the
Evaluation Database to Guide Effectiveness (EDGE) task force outcome measurements. Methods. 10 female patients from a Baheya
Center for Early Detection and Treatment of Breast Cancer facility were diagnosed with PMPS following mastectomy. The purpose of
this study is to evaluate PMPS in patients who have had mastectomy before and after a pain treatment protocol of six physiotherapy
sessions, followed by follow-up.
Results. A total of 10 women answered the questionnaires and showed changes in patient feeling is heavy sensation according to the
McGill pain Questionnaire-short form (MPQ-S.F) results (p-value = 0.02), and in patient's activities of daily living (ADLs) disability
is recreation according to the Pain disability index (PDI) results (p-value = 0.02), and in neuropathic signs and symptoms is tingling
sensation according to the Neuropathic pain scale (NPS) results (p-value = 0.02), and in patient's physical well-being is a feeling of
nausea (p-value = 0.03) and spending time in bed (p-value = 0.04).
Conclusions. According to this study, there have been initial improvements in the feeling of heaviness, neuropathic symptoms like
tingling and discomfort in the hands and feet, physical wellbeing, and facial expressions.
Trial Registration. NCT05458154
